肝门部胆管癌37例临床分析

Clinical analysis of 37 cases of hilar cholangiocarcinoma

目的探讨肝门部胆管癌的治疗方法及疗效。方法回顾性分析我院2007-01~2013-12共收治37例肝门部胆管癌患者的临床资料。结果 37例患者中12例行根治性切除,余24例均行姑息性治疗。所有患者随访年限为1~3年,行根治性切除的患者术后生存时间为9~46月;姑息性切除的患者术后生存时间为5~31月;支架引流治疗的患者术后生存时间为2~14月;而未做治疗的3例患者生存时间为27 d^5月。结论根治性切除是治疗肝门部胆管癌最有效和首选的治疗方法,联合多种影像学检查方法,并结合实验室检查综合判断,是本病早期发现与治疗的关键。

Objective To investigate the treatment method and effect of hilar cholangiocarcinoma. Methods Retro- spectively analyzed the clinical data of the 37 patients with hilar cholangiocarcinoma in our hospital from an of 2007 to Dec of 2013. Results 37 patients underwent radical resection in 12 ;more than 24 cases underwent palliative treat- ment. All patients were followed up for 1 to 3 years of age, patients after radical resection of the survival time of 9 months to 46 months;postoperative survival time of patients with palliative resection was 5 months to 31 months; stent drainage treatment the survival time of patients was 2 months to 14 months; without doing therapy three pa- tients survival time of 27 days to 5 months. Conclusion Radical resection was the treatment of hilar cholangiocarci- noma and the most effective treatment of choice. The combination of various imaging methods combined with labora- tory examinations and early detection and treatment are the key of this disease.